The Bosutinib profiling and KiSSim datasets share 108 kinases, of which 33 show high activity, mainly from the TK and STE groups. Compared to ABL1, which is one of the key targets, the TK kinases are found first in the top 35, followed by the STE kinases in the top 61 (AUC = 0.796).